Last Updated: 03/16/2016 01:08:44
EGRX Stock Chart - 1 Month
EGRX Stock Chart - 3 Month
EGRX Stock Chart - 6 Month
EGRX Stock Chart - 1 Year
EGRX Stock Chart - 2 Year
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...
Continue Reading
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...
Continue Reading
Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...
Continue Reading
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
Class Action Lawsuit Overview Against Smart Digital Group Ltd. The Rosen Law Firm, recognized for advocating for investor rights globally, has initiated a class action lawsuit aimed at purchasers of securities from Smart Digital Group Ltd. (NASDAQ: SDM). This lawsuit encompasses transactions that occurred between May 5, 2025, and September 26, 2025. Investors who made...
Continue Reading
Join the Class Action Against Zeta Global Holdings Levi & Korsinsky, LLP is reaching out to concerned investors in Zeta Global Holdings Corp. regarding a class action lawsuit that could affect many shareholders. This lawsuit aims to recover losses incurred by those negatively impacted by alleged securities fraud during a specific timeframe. Understanding the Class Action...
Continue Reading
EverBank Expands Its Equipment Finance Horizons EverBank is embarking on an exciting new journey by launching a Corporate Asset Finance division, enhancing its equipment finance capabilities significantly. This innovative step is set to offer structured equipment loans and leases to large and middle-market companies, ensuring that they receive the support they need to...
Continue Reading
USA Health and RLDatix Team Up for Enhanced Patient Safety In a significant development in the healthcare sector, USA Health has announced an expansion of its partnership with RLDatix, a trailblazer in healthcare operations software. This collaboration is designed to foster a safer healthcare environment, ensuring patients receive the highest standard of care. Empowering...
Continue Reading
Soligenix’s CiVax™: A New Approach to COVID-19 Vaccination In a remarkable leap forward in the fight against COVID-19, Soligenix, Inc. (NASDAQ: SNGX), a biopharmaceutical company dedicated to rare disease treatments, has announced significant findings about its innovative vaccine candidate, CiVax™. This thermostabilized subunit vaccine has demonstrated promising...
Continue Reading